
|Articles|March 21, 2001
US Cancer Research to Lead Singapore Genomics Program
Advertisement
WASHINGTON, DC-An American doctor has been asked to become the executive director of the Genomics Program for the Republic of Singapore.
Currently Edison T. Liu, MD, is the director of the Division of Clinical Sciences of the National Cancer Institute in Bethesda, Maryland.
Liu will help Singapore to establish itself as a biomedical science hub for the pharmaceutical, biotechnology medical devices, and healthcare services sectors. The island republic plans to spend $4 billion during the next five years on research infrastructure for biomedical sciences.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Infection Control Today
1
Chagas Disease at the US Southern Frontier: Florida’s Emerging Risk and Women’s Health Imperatives
2
States Won't Have to Report Childhood Vaccination Levels: An Infection Preventionist’s Response
3
Clean vs Sterile in Low-Risk Surgery: Rethinking Infection Risk and Surgical Costs
4
A Physician’s Warning: Ending Federal Childhood Vaccine Reporting Puts Children and Communities at Risk
5






